Dose-escalation Study of Oral CX-4945

Clinical trial NCT00891280 · UNKNOWN

Trial details

NCT number: NCT00891280
Sponsor: Cylene Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Breast Cancer Inflammatory Breast Cancer Castleman's Disease Multiple Myeloma

Start date: 2009-02-01
Primary completion: 2011-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.